“HHS cannot be led by an anti-vax, conspiracy theorist with inadequate training,” said analysts at investment firm Cantor Fitzgerald.
Related Posts
Nasdaq teeters near correction territory, down nearly 10% from record high
The Nasdaq Composite is nearing a grim milestone.
These are the 2 stocks that will win the most from Trump’s AI project Stargate, analysts say
President Donald Trump’s Stargate foray could present a major boon for these technology companies, according to Wall Street.
Jefferies upgrades Las Vegas Sands to buy, calls for a gain of more than 35%
Las Vegas Sands stands to benefit from the Chinese government’s new efforts to boost the nation’s economy, according to Jefferies.